首页> 外文期刊>Italian Journal of Medicine >End of life management in Internal Medicine Wards: a single-center real-life report
【24h】

End of life management in Internal Medicine Wards: a single-center real-life report

机译:内科病房的生命管理结束:单中心现实报告

获取原文
           

摘要

The burden of end of life in Internal Medicine wards is not negligible. However, literature evidence about the end-of-life care in Internal Medicine wards lacks. Therefore, this study aimed to report on end-of-life management in an Internal Medicine ward. We performed a retrospective study focusing on the characteristics and management of patients who consecutively died in an Italian Internal Medicine ward between July 1, 2018 and June 30, 2019. Demographic, co-morbidity, pharmacological treatment at hospital admission, and in the last 48-hours of life and procedures during hospital stay were collected. The study population was composed of 354 patients (190 females), corresponding to about ten percent of patients admitted to the ward, with a mean age ± standard deviation 83.5±10.6 years. Eighty-four percent of deaths was expected in the last 48 h before exitus. The main co-morbidities were blood hypertension (66.3%), solid or hematological malignancies (40.3%), arrhythmias (34.7%), pressure ulcers (31.3%), and diabetes (27.4%). The main causes of hospitalization were infectious diseases (23.1%) and cardiac or respiratory failure (20.9%). In seven percent of patients, palliative care had already been activated before the hospital admission. No patient had written living wills or advance directives. In the last 48 hours of life, the main pharmacological classes prescribed were opioids (63.2%), antibiotics (46.9%), and corticosteroids (46.3%). Compared with pharmacological classes prescribed at hospital admission, in the last 48 h of life, the prescription of antibiotics, corticosteroids, opioids, and benzodiazepines increased significantly, whereas the prescription of antihypertensive agents, proton pump inhibitors, and antithrombotic drugs resulted notably reduced. A written order to withdraw vital parameters acquisition or active treatment were found in 30.7% and 31.9%, respectively. In the last 48 h of life, 61% of patients underwent at least one blood assay, 34% arterial blood gas analysis, and about 35% at least one among radiography, computer tomography, magnetic resonance, or endoscopy. During the hospital stay, 9% of patients underwent blood transfusion. 28.1% of patients received a blood transfusion in the last 48 hours of life. Appropriate management of end of life represents a challenge in Internal Medicine wards.
机译:内科病房中生命结束的负担并不可忽略不计。然而,关于内科病房终生护理的文献证据缺乏。因此,本研究旨在报告内部医学病房的终生管理。我们进行了一项重点研究,重点是在2018年7月1日至2019年6月30日至6月30日之间连续死亡的患者的特征和管理。人口统计学,共同发病率,医院入院的药理治疗,以及过去的48 - 收集了住院期间的生命和程序。该研究人群由354名患者(190名女性)组成,对应于进入病房的患者的约10%,平均年龄±标准差83.5±10.6岁。在出口前的48小时之前,预计八十四个死亡人数预计。主要的持续生命性是血液高血压(66.3%),固体或血液恶性肿瘤(40.3%),心律失常(34.7%),压力溃疡(31.3%)和糖尿病(27.4%)。住院治疗的主要原因是传染病(23.1%)和心脏或呼吸衰竭(20.9%)。在七分之一的患者中,姑息治疗在医院入院前已经激活。没有患者书面生活遗嘱或预先指示。在最后48小时的生命中,规定的主要药理学课程是阿片类药物(63.2%),抗生素(46.9%)和皮质类固醇(46.3%)。与医院入院的药理课程相比,在过去48小时的生命中,抗生素,皮质类固醇,阿片类药物和苯并二氮卓和苯并二氮卓的处方显着增加,而抗高血压药物,质子泵抑制剂和抗血栓药物的处方显着降低。提取生命参数的书面订单分别以30.7%和31.9%的时间内发现。在过去的48小时内,61%的患者患有至少一个血液测定,34%动脉血液分析,约35%在射线照相,计算机断层扫描,磁共振或内窥镜检查中约35%。在住院期间,9%的患者接受输血。 28.1%的患者在过去48小时的生命中受到输血。适当管理生活结束是内部医学病房的挑战。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号